<html>
<head>PUBMED IDs for UPII</head>
<body bgcolor='#C5F0F2'><h1>UPII</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7507484/'>Precursor sequence, processing, and urothelium-specific expression of a major 15-kDa protein subunit of asymmetric unit membrane.</a> January 21  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8530366/'>Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells.</a> December 15  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9846985/'>Uroplakin gene expression by normal and neoplastic human urothelium.</a> December 10  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/12097284/'>Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.</a> July 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12446744/'>Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly.</a> November 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12474225/'>Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.</a> December 11  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12624658/'>Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.</a> March 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14963492/'>Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.</a> February 14  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15054105/'>Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.</a> April 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15300806/'>Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients.</a> August 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15699050/'>Molecular identification and characterization of Xenopus egg uroplakin III, an egg raft-associated transmembrane protein that is tyrosine-phosphorylated upon fertilization.</a> February 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16619260/'>Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.</a> April 19  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16814572/'>Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: implications for uroplakin structure and function.</a> July 4  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17295843/'>Characterization of Xenopus egg membrane microdomains containing uroplakin Ib/III complex: roles of their molecular interactions for subcellular localization and signal transduction.</a> February 14  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17476318/'>Mutational analyses of UPIIIA, SHH, EFNB2 and HNF1beta in persistent cloaca and associated kidney malformations.</a> May 4  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17880289/'>Up-regulation of urinary UPIII mRNA levels in vesicoureteral reflux patients: potential application as a screening test for vesicoureteral reflux.</a> September 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20202065/'>Evaluation of Tamm-Horsfall protein and uroplakin III for forensic identification of urine.</a> September 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20201998/'>Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma.</a> February 8  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20501863/'>Identification of genes correlated with early-stage bladder cancer progression.</a> October 1  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21658368/'>Characterization of a putative cis-regulatory element that controls transcriptional activity of the pig uroplakin II gene promoter.</a> September 10  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22218302/'>Antitumor effects of bladder cancer-specific adenovirus carrying E1A-androgen receptor in bladder cancer.</a> April 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23908596/'>p53-stabilizing agent CP-31398 prevents growth and invasion of urothelial cancer of the bladder in transgenic UPII-SV40T mice.</a> March 4  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24029776/'>Urothelial differentiation of human umbilical cord-derived mesenchymal stromal cells in vitro.</a> April 15  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24776760/'>Generation of bladder urothelium from human pluripotent stem cells under chemically defined serum- and feeder-free system.</a> January 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25085582/'>Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.</a> April 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26921394/'>High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with âˆ¼240-Fold Higher Drug Concentration in Urine than Serum.</a> December 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26921362/'>No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.</a> February 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/26921361/'>Risky business: getting a grip on BRIP.</a> February 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27687590/'>Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.</a> October 1  2016<br></body></html>
